Lower plasma collection weighs on profitability
13/08/20 -"Population confinement measures adversely impacted plasma collection volumes (especially in the US), leading to higher plasma collection costs and thereby lower profits in H1. Given that such ..."
Pages
53
Language
English
Published on
13/08/20
You may also be interested by these reports :
19/06/26
Evaluating Pharma’s Defences
17/06/26
Our target price is reduced to CHF94 (from CHF97) on the back of a lower sales base. We have also adjusted forward years’ growth, slightly increasing ...
15/06/26
The target price is upgraded on the back of higher margins in 2026. The EBITDA margin is lifted from 15.4% to 17.9% for the full year (guidance is ...
09/06/26
Our estimates for 2026-2027 have been revised downward following the reclassification of Capsules & Health Ingredients (CHI) as discontinued ...